Press release
Conversational AI to drive the Cognitive Decline Market at a CAGR of 5.8%
The cognitive decline market is dominated by a few large players, such as Eisai Co., Ltd., Novartis AG, and Pfizer Inc. However, the market is also seeing the entry of new players, such as start-ups and small companies, which are developing innovative therapies and technologies for the treatment and management of cognitive decline.
Overall, the cognitive decline market is expected to continue to grow at a significant rate in the coming years, driven by the increasing prevalence of age-related cognitive decline and the rising prevalence of chronic diseases. As the population ages and the demand for effective treatments and therapies increases, the market is likely to see further growth and development.
Get Sample Copy Of This Report To Understand The Structure Of The Complete Report@ https://www.persistencemarketresearch.com/samples/32968
Non-invasive brain stimulation (NIBS) is gaining traction as a clinically effective tool for identifying and treating a wide range of mental illnesses. Widespread use of NIBS will be contingent on its efficacy as demonstrated in sham-controlled multi-center trials, but current indications point to it having a significant impact on the treatment of disorders seen in a variety of specialties, including neurology, psychiatry, pediatrics, physical therapy, and physical medicine and rehabilitation.
Because non-invasive brain stimulation carries minimal risk, it is associated with fewer side effects and consequences. This will be one of the primary driving forces in the market over the projected period of 2022-2032.
Companies are focusing on developing innovative and competitive products to meet unmet market needs. There are multiple licensing and collaboration agreements for the development and commercialization of products in the areas of cognitive decline. New market entrants are working on an effective pricing strategy. Business units are restructuring initiatives to enhance business effectiveness. Diversification of companies' efforts is also leading to the development of other generic drugs.
Companies are entering into strategic alliances with other pharmaceutical companies and government bodies for faster development of present pipeline drugs.
To get extensive insights on key trends, request for customization here@ https://www.persistencemarketresearch.com/request-customization/32968
Key Takeaways from Market Study
By product type, drug therapy held 53% market value share in 2020.
By indication, mild cognitive impairment (MCI) held 78% market value share in 2020.
Hospitals dominated the cognitive decline market with a share of 39.1% in 2020, owing to more effective treatment within these facilities.
By region, North America dominated the global cognitive decline market with a value share of around 36.8% in 2020.
"Positive reimbursement paradigm for cognitive decline and innovative products & solutions for treatment will promote market growth," says an analyst of Persistence Market Research.
Market Competition
Key players are focusing on forming strategic partnerships through acquisitions and mergers to enhance their presence across the world, resulting in increased customer base.
In March 2021, Deutsches Zentrum für Neurodegenerative Erkrankungen and Eisai Co., Ltd. entered into a research agreement to create novel treatments for neurodegenerative disorders, including Alzheimer's disease (AD).
In August 2019, electroCore, Inc. announced a research collaboration with the Massachusetts General Hospital to explore non-invasive Vagus nerve stimulation in neuroinflammation.
What Does the Report Cover?
Persistence Market Research offers a unique perspective and actionable insights on the cognitive decline market in its latest study, presenting historical demand assessment of 2016 - 2020 and projections for 2021 - 2031.
The research study is based on the product type (drug therapy [cholinesterase inhibitors, NMDA receptor antagonists], non-invasive stimulation devices [vagus nerve stimulators, deep brain stimulators, transcranial magnetic stimulators (TMS)]), indication (mild cognitive impairment (MCI) [amnestic MCI, non-amnestic MCI], dementia), and end user (hospitals, neurology clinics/centres, retail pharmacies, home care settings) across seven key regions of the world.
Get up to 20% discount on Full Report Purchase @ https://www.persistencemarketresearch.com/checkout/32968
Read More:
https://www.medgadget.com/2022/11/the-cognitive-decline-market-to-grace-digital-transformation-curve-at-a-cagr-of-5-8.html
Related Reports:
Telemedicine Market
https://www.persistencemarketresearch.com/market-research/telemedicine-market.asp
Robotic Surgery Market
https://www.persistencemarketresearch.com/market-research/robotic-surgery-market.asp
Veterinary Teleradiology Market
https://www.persistencemarketresearch.com/market-research/veterinary-teleradiology-market.asp
Dental Radiology Equipment Market
https://www.persistencemarketresearch.com/market-research/dental-radiology-equipment-market.asp
Contact us:
Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com
About Us:
Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Conversational AI to drive the Cognitive Decline Market at a CAGR of 5.8% here
News-ID: 2863374 • Views: …
More Releases from Persistence Market Research
North America Wiring Devices Market Projected to Reach USD 26.46 Billion by 2031
Overview of the North America Wiring Devices Market
The North America wiring devices market is poised for steady growth over the forecast period, with its size estimated at US$ 18.96 billion in 2024, projected to reach US$ 26.46 billion by 2031, reflecting a CAGR of 4.9%. The market is witnessing substantial expansion due to increasing urbanization, a rising number of residential and commercial construction projects, and the adoption of energy-efficient and…
Global Forged Automotive Components Market Poised for Steady Growth, Projected t …
The global forged automotive components market is on a robust growth trajectory, currently valued at approximately US$ 50.3 billion in 2025 and forecasted to expand to US$ 70.7 billion by the end of 2032. This growth represents a compound annual growth rate (CAGR) of 5.0% over the coming decade, driven by increasing automotive production, technological advancements, and evolving consumer preferences toward durable, high-performance vehicle parts.
Forged automotive components are critical to…
Global Electric Cargo Bike Market Set to Accelerate at 11.9% CAGR, Reaching US$ …
The global electric cargo bike market is set to experience substantial growth over the coming decade, with Persistence Market Research (PMR) forecasting a compound annual growth rate (CAGR) of 11.9% from 2023 through 2032. Valued at approximately US$ 800 million in 2021, the market is expected to surge to a projected valuation of US$ 2.14 billion by the end of 2032. Notably, electric cargo bikes accounted for 66.2% of the…
Bicycle Bearings Market Set for Steady Growth with 6.5% CAGR Through 2032, Drive …
The global bicycle bearings market is poised for significant expansion over the forecast period of 2025 to 2032, according to the latest report released by Persistence Market Research. Valued at approximately US$ 5.99 billion in 2024, the market is projected to reach US$ 6.35 billion by 2025 and further escalate to nearly US$ 9.86 billion by 2032. This growth trajectory reflects a compound annual growth rate (CAGR) of 6.5%, underscoring…
More Releases for MCI
MCI Mining Construction International: Bulk Material Handling and Mining Equipme …
Image: https://www.globalnewslines.com/uploads/2025/08/0314918912f9fab867e8e6bfd24b7fb1.jpg
Founded in 1962 in Graz, Austria, MCI Mining Construction International GmbH (MCI) began as the in-house maintenance and operations partner for the country's largest open-pit coal mine. Over time, it became a trusted specialist in the relocation and refurbishment of continuous mining equipment - acquiring entire systems, overhauling them to OEM standards, and recommissioning them at new mine sites around the world.
This legacy of hands-on technical service forms the…
MCI Diagnostic Center Achieves Renewal and CAP Accreditation
Ensuring Excellence in Clinical Laboratory Testing
MCI Diagnostic Center, based in Dallas, Texas, proudly announces the successful renewal and accreditation by the College of American Pathologists (CAP). This achievement reaffirms MCI Diagnostic Center's commitment to upholding superior standards in clinical laboratory testing and patient care.
CAP accreditation is awarded to laboratories that consistently meet rigorous criteria in quality management, personnel qualifications, patient safety, and laboratory performance. By maintaining these high standards, MCI…
Mild Cognitive Impairment (MCI) Treatment Market Key Opportunities and Forecast …
The mild cognitive impairment (MCI) treatment market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 8.7% in the forecast period of 2022 to 2029 and is expected to reach USD 148,373.70 thousand by 2029.
Mild Cognitive Impairment (MCI) Treatment Market Scope and Market Size
The mild cognitive impairment (MCI) treatment market is…
Celebrating Two Decades of Empowering Development: MCI Solutions Marks its 20th …
Celebrating Two Decades of Empowering Development: MCI Solutions Marks its 20th Anniversary
MCI Solutions, a leading provider of transformative learning and development experiences, is excited to announce its 20th Anniversary this September. Over the past two decades, MCI has remained at the forefront of empowering businesses and individuals, consistently fostering growth, and driving success.
This monumental achievement wouldn't have been possible without the unwavering trust and partnership of clients, employees, and everyone…
Identify Hidden Opportunities of Brand Activation Service Market | BCD Group, Ca …
The latest survey on Worldwide Brand Activation Service Market is conducted to provide hidden gems performance analysis of Worldwide Brand Activation Service to better demonstrate competitive environment. The market Study is segmented by key a region that is accelerating the marketization. The research is based on primary and secondary statistical sources and includes both qualitative and quantitative information. The detailed information is based on current trends and historic milestones. Some…
Track v6.3 Released to Management Controls (MCi) SaaS Customers
Enhanced user experience plus new BI tools provide greater efficiency and visibility across the enterprise
HOUSTON, TX. — Sept. 13, 2016 — MANAGEMENT CONTROLS, INC. (MCi), the widely used contract cost control and turnaround cost forecasting solution, today announced the release of Track v6.3 for its Microsoft Azure clients. This release brings many customer requested features to Track including robust Business Intelligence (BI) tools, ad-hoc reporting capabilities and enhanced look and…
